San Diego-centered Viking Therapeutics marked by itself as a significant competitor while in the weight loss drug market place in February right after revealing promising knowledge from the mid-stage demo of experimental drug VK2735, which instructed it rivaled—and outperformed—Novo and Lilly drugs when specified to be a weekly injection and in